Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript February 26, 2026 Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.73 EPS, ...
An adviser's report called for more coherence and sped-up research awards at the Institute of Education Sciences.
The Kidney, Urology, and Non-Malignant Hematology (KUH) Undergraduate Research Experience program is a 12-week (8 weeks on campus), NIH-funded Summer Research Program. This program focuses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results